Register for email alerts and news feeds:
This journal | BMJ Group
rss
Postgraduate Medical Journal 2006;82:760-762; doi:10.1136/pmj.2005.041293
© 2006 BMJ Publishing Group Ltd and The Fellowship of Postgraduate Medicine.

ORIGINAL ARTICLE

Varicella vaccination in children with lymphoma and solid tumours

S Emir1, M Büyükpamukçu2, V Köseoglu3, G Hasçelik4, C Akyüz5, T Kutluk2, A Varan2

1 Department of Pediatric Oncology, SB Ankara Diskapi Children’s Training and Research Hospital, Ankara, Turkey
2 Department of Pediatric Oncology, Faculty of Medicine, Hacettepe University, Ankara, Turkey
3 Department of Pediatric Oncology, Military Medical Academy, Ankara, Turkey
4 Department of Microbiology, Faculty of Medicine, Hacettepe University, Ankara, Turkey
5 Department of Pediatric Oncology, Faculty of Medicine, Hacettepe University, Ankara, Turkey

Correspondence to:
Correspondence to:
S Emir
63. Sokak, 16/7 Emek, Ankara 6510, Turkey; emirs{at}ttnet.net.tr

Background: Varicella infection can be a severe disease, especially in immunosuppressed patients. Here, experience with live varicella vaccine to prevent varicella infection is reported in children who were undergoing treatment for lymphoma and solid tumours.

Methods: 40 children, aged between 12 months and 15 years with no clinical history of varicella, were vaccinated with live varicella vaccine. All received two doses of the vaccine subcutaneously 4 weeks apart. Serum samples were taken before the first dose and 6 weeks after the second dose of vaccine.

Results: Before vaccination, 32 patients were seronegative for varicella and eight were seropositive. Seroconversion was observed 6 weeks after the second dose in 24 of the 32 (75%) seronegative children. In 4 of 8 previously seropositive patients, antibody titres increased after immunisation. Zoster infection occurred 5 weeks after the second dose of vaccine in only one previously seronegative child. 7 children, who had responded to the vaccine, have been exposed to varicella in their families or in school without contracting clinical disease.

Conclusion: Although the small number of patients in our group prevents us from drawing definitive conclusions, the varicella vaccine seems to be well tolerated and can be administered to children with lymphoma and solid tumours undergoing treatment.

Keywords: varicella vaccination; childhood cancer; lymphoma; solid tumour; and children


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.